Demonstration of human T lymphotropic virus type I (HTLV-I) tax- specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 482-488

  Kubota, Ryuji ^a   Kawanishi, Taketo ^a   Matsubara, Hidetoshi ^b   Manns, Angela ^b   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; BLOOD LEVEL; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFLAMMATORY CELL; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SPINAL CORD DISEASE; STAINING; T LYMPHOCYTE SUBPOPULATION;

CARRIER STATE; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, TAX; HLA ANTIGENS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNE SERA; INTERFERON TYPE II; INTRACELLULAR FLUID; KINETICS; LYMPHOCYTE ACTIVATION; PARAPARESIS, TROPICAL SPASTIC; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031802995     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481.
2. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de Thé. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407.
3. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031.
4. Osame, M., M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann. Neurol. 21:117.
5. Akizuki, S., O. Nakazato, Y. Higuchi, K. Tanabe, M. Setoguchi, S. Yoshida, Y. Miyazaki, S. Yamamoto, S. Sudou, K. Sannomiya, and T. Okajima. 1987. Necropsy findings in HTLV-I associated myelopathy. Lancet 1:156.
6. Izumo, S., K. Usuku, M. Osame, K. Machigashira, M. Johnosono, and M. Nakagawa. 1988. The neuropathology of HTLV-I-associated myelopathy in Japan: report of an autopsy case and review of the literature. In HTLV-I and the Nervous System. G. C. Roman, J. C. Vernant, and M. Osame, eds. Alan R. Liss, New York, p. 261.
7. Yoshida, M., M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda, N. Eiraku, S. Ijichi, and K. Usuku. 1989. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann. Neurol 26:331.
8. Kubota, R., T. Fujiyoshi, S. Izumo, S. Yashiki, I. Maruyama, M. Osame, and S. Sonoda. 1993. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J. Neuroimmunol. 42:147.
9. Itoyama, Y., S. Minato, J. Kira, I. Goto, H. Sato, K. Okochi, and N. Yamamoto. 1988. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy. Neurology 38:1302.
10. Usuku, K., S. Sonoda, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara, and A. Igata. 1988. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23(Suppl.):S143.
11. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245.
12. Koenig, S., R. M. Woods, Y. A. Brewah, A. J. Newell, G. M. Jones, E. Boone, J. W. Adelsberger, M. W. Baseler, S. M. Robinson, and S. Jacobson. 1993. Characterization of MHC class I restricted cytotoxic T cell responses to Tax in HTLV-I infected patients with neurological disease. J. Immunol. 156:3874.
13. Elovaara, I., S. Koenig, A. Brewah, and S. Jacobson. 1993. High HTLV-I specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I associated neurological disease. J. Exp. Med. 177:1567.
14. Umehara, F., S. Izumo, M. Nakagawa, A. T. Ronquillo, K. Takahashi, K. Matsumuro, E. Sato, and M. Osame. 1993. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 52:424.
15. Moore, G. R. W., U. Traugott, L. C. Scheunberg, and C. S. Raine. 1989. Tropical spastic paraparesis: a model of virus-induced cytotoxic T-cell mediated demyelination? Ann. Neurol. 26:523.
16. Levin, M. C., T. J. Lehky, A. N. Flerlage, D. Katz, D. W. Kingma, E. S. Jaffe, J. D. Heiss, N. Patronas, H. F. McFarland, and S. Jacobson. 1997. Immunologic analysis of a spinal cord biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N. Engl. J. Med. 336:839.
17. Kira, J., Y. Itoyama, Y. Koyanagi, J. Tateishi, M. Kishikawa, S. Akizuki, I. Kobayashi, N. Toki, K. Sueishi, H. Sato, Y. Sakaki, N. Yamamoto, and I. Goto. 1992. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann. Neurol. 31:39.
18. + lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 53:23.
19. Hara, H., M. Morita, T. Iwaki, T. Hatae, Y. Itoyama, T. Kitamoto, S. Akizuki, I. Goto, and T. Watanabe. 1994. Detection of human T lymphotropic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor Vβ CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Exp. Med. 180:831.
20. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I associated myelopathy/tropical spastic paraparesis by in situ hybridization. Ann. Neurol 37:246.
21. + T lymphocytes. Ann. Neurol. 40:84.
22. Ijichi, S., N. Eiraku, M. Osame, S. Izumo, R. Kubota, I. Maruyama, M. Matsumoto, T. Niimura, and S. Sonoda. 1989. Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J. Neuroimmunol. 25:251.
23. Jacobson, S., V. Zaninovic, C. Mora, P. Rodgers-Johnson, W. A. Sheremata, C. J. Gibbs, Jr., D. C. Gajudsek, and D. E. McFarlin. 1988. Immunological findings in neurological diseases: activated lymphocytes in tropical spastic paraparesis. Ann. Neurol. 23(Suppl. 1):S196.
24. Kuroda, Y., and M. Matsui. 1993. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J. Neuroimmunol 42:223.
25. Nakamura, S., I. Nagano, M. Yoshioka, S. Shimazaki, and J. Onodera. 1993. Detection of tumor necrosis factor-α-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 42:127.
26. Nishimoto, N., K. Yoshizaki, N. Eiraku, K. Machigashira, H. Togoh, A. Ogata, T. Kuritani, M. Osame, and T. Kishimoto. 1990. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97:183.
27. Tendler, C. L., S. J. Greenberg, W. A. Blattner, A. Manns, E. Murphy, T. Fleisher, B. Hanchard, O. Morgan, J. D. Burton, D. L. Nelson, and T. A. Waldmann. 1990. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA 87:5218.
28. Tendler, C. L., S. J. Greenberg, J. D. Burton, D. Danielpour, S. J. Kim, W. A. Blattner, A. Manns, and T. A. Waldmann. 1991. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem. 46:302.
29. Umehara, F., S. Izumo, A. T. Ronquillo, K. Matsumuro, E. Sato, and M. Osame. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 53:72.
30. Greenberg, S. J., C. L. Tendler, A. Manns, C. F. Bartholomew, B. Hanchard, W. A. Blattner, and T. A. Waldmann. 1990. Altered cellular gene expression in human retroviral-associated leukemogenesis. In Human Retrovirology: HTLV. W. A. Blattner, ed. Raven Press, New York, p. 87.
31. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:5682.
32. Osame, M. 1990. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In Human Retrovirology: HTLV. W. A. Blattner, ed. Raven Press, New York, p. 191.
33. Sander, B., J. Anderson, and U. Anderson. 1991. Assessment of cytokines by immunofluorescence and the paraformaldenyde-saponin procedure. Immunol. Rev. 119:65.
34. Utz, U., S. Koenig, J. E. Coligan, and W. E. Biddison. 1992. Presentation of three different viral peptides, HTLV-I tax, HCMV gB, and influenza virus M1 is determined by common structural features of the HLA A2.1 molecule. J. Immunol. 149:214.
35. Selmaj, K. W., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339.
36. Sharief, M. K., and R. Hentges. 1991. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis, N. Engl. J. Med. 325:467.
37. Jacobson, S. 1996. Role of cellular immune responses in the pathogenesis of HTLV-I-associated neurologic disease. In Human T-Cell Lymphotropic Virus Type I. P. öllsberg and D. A. Hafler, eds. John Wiley & Sons, West Sussex, England, p. 79.
38. Höllsberg, P., and D. A. Hafler. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173.
39. Ijichi, S., S. Izumo, N. Eiraku, K. Machigashira, R. Kubota, M. Nagai, N. Ikegami, N. Kashio, F. Umehara, I. Maruyama, and M. Osame. 1993. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med. Hypotheses 41:542.